Ignite Creation Date:
2025-12-25 @ 2:33 AM
Ignite Modification Date:
2026-05-09 @ 2:20 PM
Study NCT ID:
NCT06069934
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2025-05-18
First Post:
2023-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)
Sponsor:
Prilenia
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Amyotrophic Lateral Sclerosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Amyotrophic Lateral Sclerosis | View |
| None | Pridopidine | View |
| None | Lou Gehrig's disease | View |
| None | Basal Ganglia Diseases | View |
| None | Brain Diseases | View |
| None | Central Nervous System Diseases | View |
| None | Nervous System Diseases | View |
| None | Dementia | View |
| None | Dyskinesias | View |
| None | Movement Disorders | View |
| None | Heredodegenerative Disorders, Nervous System | View |
| None | Neurodegenerative Diseases | View |
| None | Cognition Disorders | View |
| None | Neurocognitive Disorders | View |
| None | Mental Disorders | View |